The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
An end-to-end framework that enables users to implement various descriptive studies for a given set of target and outcome cohorts for data mapped to the Observational Medical Outcomes Partnership Common Data Model.
Version: | 2.1.3 |
Depends: | R (≥ 4.0.0) |
Imports: | Andromeda, DatabaseConnector (≥ 6.3.1), FeatureExtraction (≥ 3.6.0), SqlRender (≥ 1.9.0), ParallelLogger (≥ 3.0.0), ResultModelManager, checkmate, dplyr, readr, rlang |
Suggests: | devtools, testthat, kableExtra, knitr, markdown, rmarkdown, OhdsiShinyAppBuilder, shiny, withr |
Published: | 2025-03-04 |
DOI: | 10.32614/CRAN.package.Characterization |
Author: | Jenna Reps [aut, cre], Patrick Ryan [aut], Chris Knoll [aut] |
Maintainer: | Jenna Reps <jreps at its.jnj.com> |
BugReports: | https://github.com/OHDSI/Characterization/issues |
License: | Apache License 2.0 |
URL: | https://ohdsi.github.io/Characterization/, https://github.com/OHDSI/Characterization |
NeedsCompilation: | no |
CRAN checks: | Characterization results |
Reference manual: | Characterization.pdf |
Vignettes: |
Specification (source, R code) Using_Package (source, R code) |
Package source: | Characterization_2.1.3.tar.gz |
Windows binaries: | r-devel: Characterization_2.1.3.zip, r-release: Characterization_2.1.3.zip, r-oldrel: Characterization_2.1.3.zip |
macOS binaries: | r-devel (arm64): Characterization_2.1.3.tgz, r-release (arm64): Characterization_2.1.3.tgz, r-oldrel (arm64): Characterization_2.1.3.tgz, r-devel (x86_64): Characterization_2.1.3.tgz, r-release (x86_64): Characterization_2.1.3.tgz, r-oldrel (x86_64): Characterization_2.1.3.tgz |
Please use the canonical form https://CRAN.R-project.org/package=Characterization to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.